Publication

A review on the pathophysiology of asthma remission

Carpaij, O. A., Burgess, J. K., Kerstjens, H. A. M., Nawijn, M. C. & van den Berge, M., Sep-2019, In : Pharmacology & Therapeutics. 201, p. 8-24 17 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Copy link to clipboard

Documents

  • A review on the pathophysiology of asthma remission

    Final publisher's version, 842 KB, PDF document

    Request copy

DOI

Asthma is a chronic respiratory condition, which is highly prevalent worldwide. Although no cure is currently available, it is well recognized that some asthma patients can spontaneously enter remission of the disease later in life. Asthma remission is characterized by absence of symptoms and lack of asthma-medication use. Subjects in asthma remission can be divided into two groups: those in clinical remission and those in complete remission. In clinical asthma remission, subjects still have a degree of lung functional impairment or bronchial hyperresponsiveness, while in complete asthma remission, these features are no longer present. Over longer periods, the latter group is less likely to relapse. This remission group is of great scientific interest due to the higher potential to find biomarkers or biological pathways that elicit or are associated with asthma remission.

Despite the fact that the definition of asthma remission varies between studies, some factors are reproducibly observed to be associated with remitted asthma. Among these are lower levels of inflammatory markers, which are lowest in complete remission. Additionally, in both groups some degree of airway remodeling is present. Still, the pathological disease state of asthma remission has been poorly investigated. Future research should focus on at least two aspects: further characterisation of the small airways and airway walls in order to determine histologically true remission, and more thorough biological pathway analyses to explore triggers that elicit this phenomenon. Ultimately, this will result in pharmacological targets that provide the potential to steer the course of asthma towards remission. (C) 2019 Elsevier Inc. All rights reserved.

Original languageEnglish
Pages (from-to)8-24
Number of pages17
JournalPharmacology & Therapeutics
Volume201
Early online date8-May-2019
Publication statusPublished - Sep-2019

    Keywords

  • Clinical asthma remission, Complete asthma remission, Predictors, Prevalence, Biomarkers, Airway remodeling, PLASMINOGEN-ACTIVATOR INHIBITOR-1, HOUSE-DUST MITE, CHILDHOOD ASTHMA, FOLLOW-UP, NATURAL-HISTORY, ALLERGIC-ASTHMA, RISK-FACTORS, AIRWAY INFLAMMATION, CLINICAL REMISSION, ACUTE-LEUKEMIA

ID: 82080392